Sertraline in the treatment of anxiety disorders

Robert M A Hirschfeld

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Sertraline was first developed and approved for the treatment of depression. However, considerable research has been conducted on its use in anxiety disorders. This paper reviews the data emerging from controlled and open trials of the use of sertraline in anxiety disorders. Sertraline has been tested extensively in the treatment of panic and obsessive-compulsive disorders. Less extensive testing has been completed on social phobia and post-traumatic stress disorder. The reviewed studies show that sertraline is an effective and well-tolerated treatment of all of these disorders. A comparison of sertraline with other pharmacotherapeutic options shows it to be at least equivalent to other medications for anxiety disorders. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)139-157
Number of pages19
JournalDepression and Anxiety
Volume11
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Sertraline
Anxiety Disorders
Panic
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorders
Depression
Research

Keywords

  • Anxiety disorders
  • Depression
  • Obsessive-compulsive disorder
  • Panic disorder
  • Pharmacotherapy
  • PTSD
  • Sertraline
  • Social phobia
  • SSRIs

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)
  • Clinical Psychology

Cite this

Sertraline in the treatment of anxiety disorders. / Hirschfeld, Robert M A.

In: Depression and Anxiety, Vol. 11, No. 4, 2000, p. 139-157.

Research output: Contribution to journalArticle

Hirschfeld, Robert M A. / Sertraline in the treatment of anxiety disorders. In: Depression and Anxiety. 2000 ; Vol. 11, No. 4. pp. 139-157.
@article{48100ab684b64c2f9d657f9751047447,
title = "Sertraline in the treatment of anxiety disorders",
abstract = "Sertraline was first developed and approved for the treatment of depression. However, considerable research has been conducted on its use in anxiety disorders. This paper reviews the data emerging from controlled and open trials of the use of sertraline in anxiety disorders. Sertraline has been tested extensively in the treatment of panic and obsessive-compulsive disorders. Less extensive testing has been completed on social phobia and post-traumatic stress disorder. The reviewed studies show that sertraline is an effective and well-tolerated treatment of all of these disorders. A comparison of sertraline with other pharmacotherapeutic options shows it to be at least equivalent to other medications for anxiety disorders. (C) 2000 Wiley-Liss, Inc.",
keywords = "Anxiety disorders, Depression, Obsessive-compulsive disorder, Panic disorder, Pharmacotherapy, PTSD, Sertraline, Social phobia, SSRIs",
author = "Hirschfeld, {Robert M A}",
year = "2000",
doi = "10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C",
language = "English (US)",
volume = "11",
pages = "139--157",
journal = "Depression and Anxiety",
issn = "1091-4269",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Sertraline in the treatment of anxiety disorders

AU - Hirschfeld, Robert M A

PY - 2000

Y1 - 2000

N2 - Sertraline was first developed and approved for the treatment of depression. However, considerable research has been conducted on its use in anxiety disorders. This paper reviews the data emerging from controlled and open trials of the use of sertraline in anxiety disorders. Sertraline has been tested extensively in the treatment of panic and obsessive-compulsive disorders. Less extensive testing has been completed on social phobia and post-traumatic stress disorder. The reviewed studies show that sertraline is an effective and well-tolerated treatment of all of these disorders. A comparison of sertraline with other pharmacotherapeutic options shows it to be at least equivalent to other medications for anxiety disorders. (C) 2000 Wiley-Liss, Inc.

AB - Sertraline was first developed and approved for the treatment of depression. However, considerable research has been conducted on its use in anxiety disorders. This paper reviews the data emerging from controlled and open trials of the use of sertraline in anxiety disorders. Sertraline has been tested extensively in the treatment of panic and obsessive-compulsive disorders. Less extensive testing has been completed on social phobia and post-traumatic stress disorder. The reviewed studies show that sertraline is an effective and well-tolerated treatment of all of these disorders. A comparison of sertraline with other pharmacotherapeutic options shows it to be at least equivalent to other medications for anxiety disorders. (C) 2000 Wiley-Liss, Inc.

KW - Anxiety disorders

KW - Depression

KW - Obsessive-compulsive disorder

KW - Panic disorder

KW - Pharmacotherapy

KW - PTSD

KW - Sertraline

KW - Social phobia

KW - SSRIs

UR - http://www.scopus.com/inward/record.url?scp=0033851819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033851819&partnerID=8YFLogxK

U2 - 10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C

DO - 10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C

M3 - Article

VL - 11

SP - 139

EP - 157

JO - Depression and Anxiety

JF - Depression and Anxiety

SN - 1091-4269

IS - 4

ER -